Bisphosphonate guidelines for treatment and prevention of myeloma bone disease

Author:

Lee Oi Lin1,Horvath Noemi12,Lee Cindy23,Joshua Doug245,Ho Joy245,Szer Jeff267ORCID,Quach Hang268,Spencer Andrew269,Harrison Simon2610,Mollee Peter21112,Roberts Andrew W.26713,Talaulikar Dipti21415,Brown Ross24,Augustson Bradley216,Ling Silvia21718,Jaksic Wilfrid23,Gibson John245,Kalff Anna29,Johnston Anna21920,Kalro Akash221,Ward Chris2522,Prince H. Miles2106,Zannettino Andrew22324ORCID

Affiliation:

1. Department of Haematology; Royal Adelaide Hospital; Adelaide South Australia Australia

2. Medical and Scientific Advisory Group, Myeloma Australia; Melbourne Victoria Australia

3. Department of Haematology; Queen Elizabeth Hospital; Adelaide South Australia Australia

4. Department of Haematology; Royal Prince Alfred Hospital; Sydney New South Wales Australia

5. Department of Cancer and Haematology, Sydney Medical School; University of Sydney; Sydney New South Wales Australia

6. Faculty of Medicine, Dentistry and Health Sciences; University of Melbourne; Melbourne Victoria Australia

7. Department of Clinical Haematology and BMT; Royal Melbourne Hospital; Melbourne Victoria Australia

8. Department of Haematology; St Vincent's Hospital; Melbourne Victoria Australia

9. Department of Haematology; The Alfred Hospital; Melbourne Victoria Australia

10. Department of Haematology; Peter MacCallum Cancer Centre; Melbourne Victoria Australia

11. Department of Haematology; Princess Alexandra Hospital; Brisbane Queensland Australia

12. School of Medicine; University of Queensland; Brisbane Queensland Australia

13. Walter and Eliza Hall Institute of Medical Research; Melbourne Victoria Australia

14. Department of Haematology; Canberra Hospital; Canberra Australian Capital Territory Australia

15. College of Medicine, Biology and Environment; Australian National University; Canberra Australian Capital Territory Australia

16. Department of Haematology; Sir Charles Gairdner Hospital; Perth Western Australia Australia

17. Department of Haematology; Liverpool Hospital; Sydney New South Wales Australia

18. South Western Sydney Clinical School; University of New South Wales; Sydney New South Wales Australia

19. Department of Haematology; Royal Hobart Hospital; Hobart Tasmania Australia

20. Faculty of Health; University of Tasmania; Hobart Tasmania Australia

21. Department of Haematology; Royal Darwin Hospital; Darwin Northern Territory Australia

22. Department of Medicine; Royal North Shore Hospital; Sydney New South Wales Australia

23. Adelaide Medical School, Faculty of Health and Medical Sciences; University of Adelaide; Adelaide South Australia Australia

24. Cancer Theme; South Australian Health and Medical Research Institute; Adelaide South Australia Australia

Publisher

Wiley

Subject

Internal Medicine

Reference113 articles.

1. Multiple myeloma: review of 869 cases;Kyle;Mayo Clin Proc,1975

2. Skeletal complications of malignancy;Coleman;Cancer,1997

3. Effect of pathologic fractures on survival in multiple myeloma patients: a case control study;Sonmez;J Exp Clin Cancer Res,2008

4. National Health and Medical Research Council 2000 http://www.nhmrc.gov.au/guidelines-publications/cp69

5. National Health and Medical Research Council http://www.nhmrc.gov.au/guidelines-publications/information-guideline-developers/resources-guideline-developers

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3